The term registry in individual application to patients with acute coronary syndrome (ACS) is discussed in this review. The author performs a detailed analysis of literature concerning objectives and goals of registries and their significance in clinical practice. The marked differences can be found between registries and randomized clinical trials (RCT). After the example of ACS registries the author shows the influence of information received according to registries limits on the formation of recommendations on treatment of patients with ACS.